Investigation Reveals FDA Allows Drugs Without Proven Clinical Benefit to Languish for Years on Accelerated Pathway

Process plagued by missing efficacy data and questionable evidence; Some experts argue that FDA’s standards for evidence are too low. Since the US Food and...

The post Investigation Reveals FDA Allows Drugs Without Proven Clinical Benefit to Languish for Years on Accelerated Pathway appeared first on SciTechDaily.

from SciTechDaily https://ift.tt/3BPcUYV